![]() |
| Neoplasms of the CNS |
|
Free Subscription
1 AJNR Am J Neuroradiol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Neoplasms of the CNS is free of charge.
Prediction Models of IDH and ATRX Gene Status in Diffuse Gliomas Based on VASARI
Features.
AJNR Am J Neuroradiol. 2025 Oct 17:ajnr.A9049. doi: 10.3174/ajnr.A9049.
PubMed
Abstract available
Different detection rates of brain metastasis in different pathological types of
lung cancer by (18)F-FAPI PET/CT.
BMC Cancer. 2025;25:1620.
PubMed
Abstract available
A retrospective study of 30 cases evaluating the efficacy and safety of anlotinib
plus Temozolomide for recurrent/residual glioma from a single center.
BMC Cancer. 2025;25:1623.
PubMed
Cyclic cytokines mediated the effect of immune cells on meningioma: a two-step,
mediation mendelian randomization study.
BMC Cancer. 2025;25:1633.
PubMed
Abstract available
A rare case of diffuse myelitis following intracystic bleomycin chemotherapy for
craniopharyngioma.
Childs Nerv Syst. 2025;41:327.
PubMed
Abstract available
Desmoplastic infantile ganglioglioma and astrocytoma: A narrative review of the
literature.
Childs Nerv Syst. 2025;41:324.
PubMed
Abstract available
Long-term trends and disparities in primary intracranial germ cell tumor
incidence and mortality for child and adolescent in the USA.
Childs Nerv Syst. 2025;41:319.
PubMed
Abstract available
The effect of oncolytic virotherapy on pediatric brain tumor- a systematic
review.
Childs Nerv Syst. 2025;41:315.
PubMed
Abstract available
Redefining Neurocognitive Outcomes After Radiation for Brain Metastases: A
Patient-Level Meta-Analysis of Recovery Following Initial Decline.
J Natl Cancer Inst. 2025 Oct 22:djaf264. doi: 10.1093.
PubMed
Abstract available
Perioperative leukocyte-plateletcrit shift as a prognostic signature in
glioblastoma.
J Neurooncol. 2025;176:27.
PubMed
Abstract available
Dynamic reorganization of individual-level morphological networks in unilateral
frontal lobe low-grade gliomas: a longitudinal study.
J Neurooncol. 2025;176:29.
PubMed
Post-operative events following elective craniotomy for tumor in children.
J Neurooncol. 2025;176:28.
PubMed
Abstract available
Clinical utility of repeat brain biopsy in recurrent or refractory primary CNS
lymphoma - a diagnostic dilemma.
J Neurooncol. 2025;176:32.
PubMed
Abstract available
MiR-148a-3p/SIRT7 axis promotes glioma progression and regulates temozolomide
chemosensitivity.
J Neurooncol. 2025;176:31.
PubMed
Abstract available
Frameless linac-based radiosurgery for benign intracranial tumors treated with
HyperArc: analysis of tumor control and toxicity.
J Neurooncol. 2025;176:33.
PubMed
Abstract available
Circadian variation in MGMT promoter methylation and expression predicts
sensitivity to temozolomide in glioblastoma.
J Neurooncol. 2025;176:36.
PubMed
Abstract available
Stereotactic radiosurgery for patients with brain metastases from nasopharyngeal
carcinoma.
J Neurooncol. 2025;176:35.
PubMed
Abstract available
miR-21 as a diagnostic and prognostic biomarker in glioma: tissue and serum
expression analysis in a Pakistani cohort.
J Neurooncol. 2025;176:34.
PubMed
Abstract available
Investigating glioblastoma chemoresistance: a meta-analysis of microRNA
signatures and gene networks.
J Neurooncol. 2025;176:38.
PubMed
Abstract available
Brain state theory as a comprehensive model for addressing the "non-eloquent"
brain in glioma surgery.
J Neurooncol. 2025;176:39.
PubMed
Abstract available
SUV-max of (68)Ga-DOTATATE PET/CT correlates with WHO grade and RNA risk
classification in meningioma.
J Neurooncol. 2025;176:37.
PubMed
Abstract available
Tumor-associated macrophages in feline meningiomas: Exploring their prognostic
significance.
J Neuropathol Exp Neurol. 2025 Oct 21:nlaf119. doi: 10.1093.
PubMed
Abstract available
Integrated clinical and molecular landscape of disseminated pediatric low-grade
glioma.
Neuro Oncol. 2025 Oct 21:noaf245. doi: 10.1093.
PubMed
Abstract available
Structural network alterations associated with surgical resection of temporal
gliomas.
Neurol Res. 2025 Oct 22:1-12. doi: 10.1080/01616412.2025.2577967.
PubMed
Abstract available
Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3
Glioma Patients: A Prospective Observational Study.
Neurology. 2025;105:e213880.
PubMed
Exploring the Diagnostic Test Accuracy of MicroRNAs as Potential Biomarkers for
Glioblastoma: Systematic Review and Meta-Analysis.
Neurosurgery. 2025 Oct 23. doi: 10.1227/neu.0000000000003813.
PubMed
Abstract available
HRH1-targeting mAb: a precision therapeutic strategy for Glioblastoma.
Oncogene. 2025 Oct 23. doi: 10.1038/s41388-025-03613.
PubMed
Abstract available
Thank you for your interest in scientific medicine.